Retrospective Cohort Study
Copyright ©The Author(s) 2017.
World J Gastroenterol. Aug 21, 2017; 23(31): 5746-5754
Published online Aug 21, 2017. doi: 10.3748/wjg.v23.i31.5746
Figure 1
Figure 1 Diagnostic value of aspartate aminotransferase-to-platelet ratio index in different groups of chronic hepatitis B patients. PNALT: Persistently normal alanine transaminase; APRI: Aspartate aminotransferase-to-platelet ratio index; AUC: Areas under the curve.
Figure 2
Figure 2 Diagnostic value of FIB-4 in different groups of chronic hepatitis B patients. PNALT: Persistently normal alanine transaminase; AUC: Areas under the curve.
Figure 3
Figure 3 Diagnostic value of liver stiffness measurement in different groups of chronic hepatitis B patients. PNALT: Persistently normal alanine transaminase; LSM: Liver stiffness measurement; AUC: Areas under the curve.
Figure 4
Figure 4 Comparison of the diagnostic value of the three noninvasive liver fibrosis markers in different groups of chronic hepatitis B patients. APRI: Aspartate aminotransferase-to-platelet ratio index; FIB-4: Fibrosis-4; LSM: Liver stiffness measurement.